Prebiotics and resistance to gastrointestinal infections

被引:192
作者
Gibson, GR [1 ]
McCartney, AL [1 ]
Rastall, RA [1 ]
机构
[1] Univ Reading, Sch Food Biosci, Food Microbial Sci Unit, Reading RG6 6AP, Berks, England
关键词
gut pathogens; prebiotics; bifidobacteria; inulin;
D O I
10.1079/BJN20041343
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Acute gut disorder is a cause for significant medicinal and economic concern. Certain individual pathogens of the gut, often transmitted in food or water, have the ability to cause severe discomfort. There is a need to manage such conditions more effectively. The route of reducing the risk of intestinal infections through diet remains largely unexplored. Antibiotics are effective at inhibiting pathogens; however, these should not be prescribed in the absence of disease and therefore cannot be used prophylactically. Moreover, their indiscriminate use has reduced effectiveness. Evidence has accumulated to suggest that some of the health-promoting bacteria in the gut (probiotics) can elicit a multiplicity of inhibitory effects against pathogens. Hence, an increase in their numbers should prove effective at repressing pathogen colonisation if/when infectious agents enter the gut. As such, fortification of indigenous bifidobacteria/lactobacilli by using prebiotics should improve protection. There are a number of potential mechanisms for lactic acid bacteria to reduce intestinal infections. Firstly, metabolic endproducts such as acids excreted by these micro-organisms may lower the gut pH to levels below those at which pathogens are able to effectively compete. Also, many lactobacilli and bifidobacteria species are able to excrete natural antibiotics, which can have a broad spectrum of activity. Other mechanisms include an improved immune stimulation, competition for nutrients and blocking of pathogen adhesion sites in the gut. Many intestinal pathogens like type 1 fimbriated Escherichia coli, salmonellae and campylobacters utilise oligosaccharide receptor sites in the gut. Once established, they can then cause gastroenteritis through invasive and/or toxin forming properties. One extrapolation of the prebiotic concept is to simulate such receptor sites in the gut lumen. Hence, the pathogen is 'decoyed' into not binding at the host mucosal interface. The combined effects of prebiotics upon the lactic acid flora and anti-adhesive strategies may lead towards new dietary interventions against food safety agents.
引用
收藏
页码:S31 / S34
页数:4
相关论文
共 29 条
[21]  
Meyer PD, 2000, AGRO FOOD IND HI TEC, V11, P18
[22]   BIFIDOBACTERIA AND THEIR ROLE IN HUMAN HEALTH [J].
MITSUOKA, T .
JOURNAL OF INDUSTRIAL MICROBIOLOGY, 1990, 6 (04) :263-267
[23]  
MIZOTA T, 1996, B INT DAIRY FED, V313, P31
[24]   Evaluation of fructooligosaccharide supplementation of oral electrolyte solutions for treatment of diarrhea - Recovery of the intestinal bacteria [J].
Oli, MW ;
Petschow, BW ;
Buddington, RK .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (01) :138-147
[25]   EXPRESSION OF LISTERIOLYSIN AND PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-C IS REPRESSED BY THE PLANT-DERIVED MOLECULE CELLOBIOSE IN LISTERIA-MONOCYTOGENES [J].
PARK, SF ;
KROLL, RG .
MOLECULAR MICROBIOLOGY, 1993, 8 (04) :653-661
[26]   Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharide as selective substrate [J].
Sghir, A ;
Chow, JM ;
Mackie, RI .
JOURNAL OF APPLIED MICROBIOLOGY, 1998, 85 (04) :769-777
[27]   A human volunteer study on the prebiotic effects of HP-inulin -: Faecal bacteria enumerated using fluorescent in situ hybridisation (FISH) [J].
Tuohy, KM ;
Finlay, RK ;
Wynne, AG ;
Gibson, GR .
ANAEROBE, 2001, 7 (03) :113-118
[28]   EFFECTS OF THE IN-VITRO FERMENTATION OF OLIGOFRUCTOSE AND INULIN BY BACTERIA GROWING IN THE HUMAN LARGE-INTESTINE [J].
WANG, X ;
GIBSON, GR .
JOURNAL OF APPLIED BACTERIOLOGY, 1993, 75 (04) :373-380
[29]   INFLUENCE OF DIETARY NEOSUGAR ON SELECTED BACTERIAL GROUPS OF THE HUMAN FECAL MICROBIOTA [J].
WILLIAMS, CH ;
WITHERLY, SA ;
BUDDINGTON, RK .
MICROBIAL ECOLOGY IN HEALTH AND DISEASE, 1994, 7 (02) :91-97